Benzinga

JULY 28, 2023

and PLANO, Texas, July 28, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. and PLANO, Texas, July 28, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. NASDAQ: BIIB ) and Reata Pharmaceuticals, Inc. Biogen expects this acquisition to be accounted for as a business combination. CAMBRIDGE, Mass. CAMBRIDGE, Mass.

Enterprise Value 40

Enterprise Value Finance 40

Benzinga

SEPTEMBER 26, 2023

Reata acquisition bolsters Biogen's rare disease portfolio with the addition of SKYCLARYS ® (omaveloxolone), the first and only FDA approved treatment for Friedreich's ataxia in the U.S. 26, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. NASDAQ: BIIB ) – has completed the acquisition of Reata Pharmaceuticals, Inc.

Marketability 40

Marketability 40

Benzinga

JULY 28, 2023

Earlier today, Biogen Inc (NASDAQ: BIIB ) agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA ) for $172.50 The analysts say the asset and other pipeline Nrf2 activators fit well within the company's rare neurology franchise. per share in cash, reflecting an enterprise value of approximately $7.3

Enterprise Value 52

Enterprise Value 52

Benzinga

MAY 10, 2022

Pfizer Inc (NYSE: PFE ) will acquire Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN ) for $148.50 Praxis Precision Medicines Inc (NASDAQ: PRAX ) announced topline results from Part B of its Phase 2a study evaluating the safety and efficacy of PRAX-944 for essential tremors. Pfizer Acquires Biohaven For $11B.

Marketability 97

Marketability Finance 97

Harvard Corporate Governance

AUGUST 5, 2022

billion cash acquisition of Bioverative, Inc. which had recently been spun off from Biogen, Inc.) Related research from the Program on Corporate Governance includes Independent Directors and Controlling Shareholders (discussed on the Forum here ) by Lucian Bebchuk and Assaf Hamdani. The Goldstein v. by Sanofi, S.A.

203

203

Reynolds Holding

MARCH 27, 2023

We examine developments in federal securities litigation involving special purpose acquisition companies. This figure is significantly lower than in 2016, when the Delaware Court of Chancery effectively put an end to the practice of disclosure-only settlements in In re Trulia Inc. Stockholder Litigation , 29 A.3d 3d 884 (Del.

Technology 59

Technology Start-ups Compliance Finance 59